Tonix Pharmaceuticals Holding Corp.

Healthcare · Biotechnology · United States

Last price 5.28 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 90.56M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingu...